Approval · Notice of Compliance 24429 · 2020
LUXTURNA: Notice of Compliance 24429
Issued October 13, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24429
- Date
- October 13, 2020
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LUXTURNA | 02505851 | Marketed |
Medicinal ingredients
- VORETIGENE NEPARVOVEC 500,000,000 UNIT per ML